English | हिंदी

Start-up (Alfaleus) of Sandal Kotawala (M.Tech student) has won the 12th CavinKare-MMA ChinniKrishnan Award




Start-up (Alfaleus) of Sandal Kotawala (M.Tech student) has won the 12th CavinKare-MMA ChinniKrishnan Award

Alfaleus Tech, a start-up of IIT-H M. Tech student Mr. Sandal Kotawala, based at IIT Hyderabad Research Park has won the prestigious ChinniKrishnan award by CavinKare and Madras Management Association (MMA) for its innovation Intelligent Vision Analyser (iVA). Award being received by its founder Mr. Sandal Kotawala and Technical Director - Dr. P. Arulmozhivarman at a grand event at IIT Madras Research Park, Chennai, Tamil Nadu, India.

ChinniKrishnan award is an annual award to pay tribute to entrepreneurs who exemplify the visionary, innovative, and ideation-driven qualities embodied by the late Shri. R. Chinnikrishnan, the father of C.K Ranganathan, Chairman & Managing Director of CavinKare Pvt Ltd. These awards acknowledge pioneering entrepreneurs based on the originality of their innovations, their positive impact on society, their potential for scalability and sustainability. This is the 12th edition of ChinniKrishnan award, for which more than 200 applications were received from Pan India. And 3 winners are chosen after a month-long evaluation by an esteemed jury.

Alfaleus Tech was chosen among the top 3 winners and Rupees 1 lac cash prize along with mentoring support was being presented by Mr. Suresh Narayanan, Chairman & Managing Director, Nestle India Limited and Mr. C K Ranganathan, the Chairman & Managing Director of CavinKare Pvt Ltd.

Alfaleus has been supported by Aravind Eye Hospital, Pondicherry from its very inception in terms of idea validation, prototyping, clinical feedback and validation. It has developed a virtual reality (VR) based portable visual field perimeter, called Intelligent Vision Analyser that can be used for conducting visual field testing at one-tenth the cost of conventional equipment. Moreover, the solution is portable and easy to use, can be taken to the field for eye camps and is more inclusive for immobile patients.

picture-1
picture-2